In p18−/− cells, TGFβ treatment resulted in modest changes in EMT marker genes (increase of mesenchymal and decrease of epithelial genes), which was likely due to the diminished Tgfβr2 expression observed in these tumor cells. This evidence concerns the gene TGFBR2 and neoplasm.